Literature DB >> 19562279

Parathyroid hormone-dependent hypercalcemia.

Judit Toke1, Attila Patócs, Katalin Balogh, Péter Gergics, Balázs Stenczer, Károly Rácz, Miklós Tóth.   

Abstract

The past fifteen years have resulted in great progress in our understanding of the pathogenesis and pathophysiology of hypercalcemic disorders occurring either sporadically or in a familial setting. This paper briefly reviews the clinically most important new knowledge on sporadic and hereditary forms of parathyroid hormone-dependent hypercalcemic disorders, with special emphasis on familial syndromes such as multiple endocrine neoplasia type 1 and type 2A, hyperparathyroidism-jaw tumor syndrome, familial isolated hyperparathyroidism, familial hypocalciuric hypercalcemia and neonatal severe primary hyperparathyroidism. In addition, the authors briefly present the most important clinical characteristics of 141 patients with parathyroid hormone-dependent hypercalcemia, including index patients of 18 families with hereditary disorders, diagnosed in a Hungarian endocrine center between 1997 and 2007.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19562279     DOI: 10.1007/s00508-009-1149-z

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  57 in total

1.  Casting new light on the clinical spectrum of neonatal severe hyperparathyroidism.

Authors:  S Pearce; B Steinmann
Journal:  Clin Endocrinol (Oxf)       Date:  1999-06       Impact factor: 3.478

2.  Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.

Authors:  P Ferolla; A Falchetti; P Filosso; P Tomassetti; G Tamburrano; N Avenia; G Daddi; F Puma; R Ribacchi; F Santeusanio; G Angeletti; M L Brandi
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

3.  Expression and characterization of inactivating and activating mutations in the human Ca2+o-sensing receptor.

Authors:  M Bai; S Quinn; S Trivedi; O Kifor; S H Pearce; M R Pollak; K Krapcho; S C Hebert; E M Brown
Journal:  J Biol Chem       Date:  1996-08-09       Impact factor: 5.157

4.  Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia.

Authors:  Bryan K Ward; Aaron L Magno; Bradley J Blitvich; Alexander J Rea; Bronwyn G A Stuckey; John P Walsh; Thomas Ratajczak
Journal:  Clin Endocrinol (Oxf)       Date:  2006-05       Impact factor: 3.478

Review 5.  Guidelines for diagnosis and therapy of MEN type 1 and type 2.

Authors:  M L Brandi; R F Gagel; A Angeli; J P Bilezikian; P Beck-Peccoz; C Bordi; B Conte-Devolx; A Falchetti; R G Gheri; A Libroia; C J Lips; G Lombardi; M Mannelli; F Pacini; B A Ponder; F Raue; B Skogseid; G Tamburrano; R V Thakker; N W Thompson; P Tomassetti; F Tonelli; S A Wells; S J Marx
Journal:  J Clin Endocrinol Metab       Date:  2001-12       Impact factor: 5.958

6.  Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Authors:  Laura A Lambert; Suzanne E Shapiro; Jeffrey E Lee; Nancy D Perrier; Mylene Truong; Michael J Wallace; Ana O Hoff; Robert F Gagel; Douglas B Evans
Journal:  Arch Surg       Date:  2005-04

7.  Blood ionized calcium is associated with clustered polymorphisms in the carboxyl-terminal tail of the calcium-sensing receptor.

Authors:  Alfredo Scillitani; Vito Guarnieri; Simona De Geronimo; Lucia Anna Muscarella; Claudia Battista; Leonardo D'Agruma; Francesco Bertoldo; Cinzia Florio; Salvatore Minisola; Geoffrey N Hendy; David E C Cole
Journal:  J Clin Endocrinol Metab       Date:  2004-11       Impact factor: 5.958

8.  Frequency of the calcium-sensing receptor variant A986S in patients with primary hyperparathyroidism.

Authors:  S Miedlich; P Lamesch; A Mueller; R Paschke
Journal:  Eur J Endocrinol       Date:  2001-10       Impact factor: 6.664

9.  Calcium infusion suggests a "set-point" abnormality of parathyroid gland function in familial benign hypercalcemia and more complex disturbances in primary hyperparathyroidism.

Authors:  S Khosla; P R Ebeling; A F Firek; M M Burritt; P C Kao; H Heath
Journal:  J Clin Endocrinol Metab       Date:  1993-03       Impact factor: 5.958

10.  Mutations in the human Ca(2+)-sensing receptor gene cause familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism.

Authors:  M R Pollak; E M Brown; Y H Chou; S C Hebert; S J Marx; B Steinmann; T Levi; C E Seidman; J G Seidman
Journal:  Cell       Date:  1993-12-31       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.